The global Human Immunodeficiency Virus (HIV) Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV) Therapeutics.

Report Scope

The Human Immunodeficiency Virus (HIV) Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunodeficiency Virus (HIV) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Immunodeficiency Virus (HIV) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Immunodeficiency Virus (HIV) Therapeutics Market Report

Report Metric	Details
Report Name	Human Immunodeficiency Virus (HIV) Therapeutics Market
CAGR	5%
Segment by Type	NRTIs NNRTIs Entry and Fusion Inhibitors Protease Inhibitors Integrase Inhibitors Coreceptor Antagonists
Segment by Application	Hospitals Clinics Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The main players in the Human Immunodeficiency Virus (HIV) Therapeutics Market are ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.

What are the Application segmentation covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The Applications covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The Types covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report are NRTIs, NNRTIs, Entry and Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors, Coreceptor Antagonists

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NRTIs

1.2.3 NNRTIs

1.2.4 Entry and Fusion Inhibitors

1.2.5 Protease Inhibitors

1.2.6 Integrase Inhibitors

1.2.7 Coreceptor Antagonists

1.3 Market by Application

1.3.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Labs

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Perspective (2019-2030)

2.2 Human Immunodeficiency Virus (HIV) Therapeutics Growth Trends by Region

2.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Dynamics

2.3.1 Human Immunodeficiency Virus (HIV) Therapeutics Industry Trends

2.3.2 Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

2.3.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

2.3.4 Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue

3.1.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Therapeutics Revenue

3.4 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio

3.4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2023

3.5 Human Immunodeficiency Virus (HIV) Therapeutics Key Players Head office and Area Served

3.6 Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service

3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Type

4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2025-2030)

5 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Application

5.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2019-2030)

6.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024)

6.4 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2019-2030)

7.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024)

7.4 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2019-2030)

9.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ViiV Healthcare

11.1.1 ViiV Healthcare Company Detail

11.1.2 ViiV Healthcare Business Overview

11.1.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.1.4 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.1.5 ViiV Healthcare Recent Development

11.2 Mylan

11.2.1 Mylan Company Detail

11.2.2 Mylan Business Overview

11.2.3 Mylan Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.2.4 Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.2.5 Mylan Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.3.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.3.5 AbbVie Recent Development

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Detail

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.4.4 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.4.5 Merck & Co., Inc. Recent Development

11.5 Bristol-Myers Squibb Company

11.5.1 Bristol-Myers Squibb Company Company Detail

11.5.2 Bristol-Myers Squibb Company Business Overview

11.5.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.5.4 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.5.5 Bristol-Myers Squibb Company Recent Development

11.6 Boehringer Ingelheim GmbH

11.6.1 Boehringer Ingelheim GmbH Company Detail

11.6.2 Boehringer Ingelheim GmbH Business Overview

11.6.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.6.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.6.5 Boehringer Ingelheim GmbH Recent Development

11.7 Genentech, Inc.

11.7.1 Genentech, Inc. Company Detail

11.7.2 Genentech, Inc. Business Overview

11.7.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.7.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.7.5 Genentech, Inc. Recent Development

11.8 Cipla, Inc.

11.8.1 Cipla, Inc. Company Detail

11.8.2 Cipla, Inc. Business Overview

11.8.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.8.4 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.8.5 Cipla, Inc. Recent Development

11.9 Boehringer Ingelheim GmbH

11.9.1 Boehringer Ingelheim GmbH Company Detail

11.9.2 Boehringer Ingelheim GmbH Business Overview

11.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.9.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.9.5 Boehringer Ingelheim GmbH Recent Development

11.10 Genentech, Inc.

11.10.1 Genentech, Inc. Company Detail

11.10.2 Genentech, Inc. Business Overview

11.10.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.10.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

11.10.5 Genentech, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol Myers Squibb Company

Boehringer Ingelheim GmbH

Genentech Inc

Cipla Ltd

List of Tables

Table 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NRTIs

Table 3. Key Players of NNRTIs

Table 4. Key Players of Entry and Fusion Inhibitors

Table 5. Key Players of Protease Inhibitors

Table 6. Key Players of Integrase Inhibitors

Table 7. Key Players of Coreceptor Antagonists

Table 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2019-2024)

Table 12. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2025-2030)

Table 14. Human Immunodeficiency Virus (HIV) Therapeutics Market Trends

Table 15. Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

Table 16. Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

Table 17. Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

Table 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players (2019-2024)

Table 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2023)

Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV) Therapeutics Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service

Table 25. Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2019-2024)

Table 29. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2025-2030)

Table 31. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2019-2024)

Table 33. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2025-2030)

Table 35. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 50. ViiV Healthcare Company Detail

Table 51. ViiV Healthcare Business Overview

Table 52. ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 53. ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 54. ViiV Healthcare Recent Development

Table 55. Mylan Company Detail

Table 56. Mylan Business Overview

Table 57. Mylan Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 58. Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 59. Mylan Recent Development

Table 60. AbbVie Company Detail

Table 61. AbbVie Business Overview

Table 62. AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 63. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 64. AbbVie Recent Development

Table 65. Merck & Co., Inc. Company Detail

Table 66. Merck & Co., Inc. Business Overview

Table 67. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 68. Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Merck & Co., Inc. Recent Development

Table 70. Bristol-Myers Squibb Company Company Detail

Table 71. Bristol-Myers Squibb Company Business Overview

Table 72. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 73. Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Bristol-Myers Squibb Company Recent Development

Table 75. Boehringer Ingelheim GmbH Company Detail

Table 76. Boehringer Ingelheim GmbH Business Overview

Table 77. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 78. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Boehringer Ingelheim GmbH Recent Development

Table 80. Genentech, Inc. Company Detail

Table 81. Genentech, Inc. Business Overview

Table 82. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 83. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 84. Genentech, Inc. Recent Development

Table 85. Cipla, Inc. Company Detail

Table 86. Cipla, Inc. Business Overview

Table 87. Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 88. Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Cipla, Inc. Recent Development

Table 90. Boehringer Ingelheim GmbH Company Detail

Table 91. Boehringer Ingelheim GmbH Business Overview

Table 92. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 93. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Boehringer Ingelheim GmbH Recent Development

Table 95. Genentech, Inc. Company Detail

Table 96. Genentech, Inc. Business Overview

Table 97. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 98. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024) & (US$ Million)

Table 99. Genentech, Inc. Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. NRTIs Features

Figure 4. NNRTIs Features

Figure 5. Entry and Fusion Inhibitors Features

Figure 6. Protease Inhibitors Features

Figure 7. Integrase Inhibitors Features

Figure 8. Coreceptor Antagonists Features

Figure 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Labs Case Studies

Figure 14. Human Immunodeficiency Virus (HIV) Therapeutics Report Years Considered

Figure 15. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region: 2023 VS 2030

Figure 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players in 2023

Figure 19. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2023

Figure 21. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2019-2030)

Figure 23. United States Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2019-2030)

Figure 35. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2019-2030)

Figure 43. Mexico Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2019-2030)

Figure 47. Turkey Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. ViiV Healthcare Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 50. Mylan Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 51. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 52. Merck & Co., Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 54. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 55. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 56. Cipla, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 57. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 58. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions